Navigation Links
Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
Date:2/12/2009

herapy program, allowing these centers to pay for the service when the boost treatment is delivered, providing a more attractive financing model while delivering more treatment options to their patients."

"Advanced Radiation Therapy is pleased to partner with Nucletron," stated Piran Sioshansi, Ph.D., president and chief executive officer of ART. "Our goal is to make the AccuBoost treatment option available to as many women as possible, all over the world. The market reach and expertise in HDR brachytherapy provided by Nucletron will help us realize this goal. Together we can accelerate the introduction of this new, non-invasive, image-guided procedure to more clinical sites worldwide."

Clinical reports indicate that patients with early stage breast cancer have the best outcomes when the breast conserving lumpectomy procedure is combined with a full course of whole breast irradiation and partial breast boost dose. ART's AccuBoost combines a mammography procedure for real-time image guidance to accurately target the boost dose, and precise dose delivery by Nucletron's microSelectron family of HDR afterloaders. By increasing the accuracy of the dose-targeting and reducing the unintentional exposure to healthy tissue, including the heart, lungs, and skin, AccuBoost is expected to improve patient outcomes, minimizes side effects and result in a better cosmetic results.

Representatives will be on hand to discuss this strategic partnership at the American Brachytherapy Society's School of Breast Brachytherapy and Brachytherapy Physics in San Antonio, TX on February 12-13, and the 2009 ACRO Annual Meeting in Las Vegas, NV on February 26-27.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities thro
'/>"/>

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
2. Study finds race and ethnicity affect use of hospice services among patients with advanced cancer
3. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
4. Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
5. ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates
6. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
7. Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc.
8. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
9. Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
10. The Quantum Group and IBM Announce Hosting Agreement for Advanced Healthcare Solutions
11. Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutica... Shareholders will be held on Monday, December 21,...pproval of two special resolutions. The first spec...e of all or substantially all of the assets of NUC...he asset purchase agreement dated November 10, 200...
(Date:11/20/2009).... 20 The United States ... make essential changes its health reform bill in ...ding and conscience protection on abortion, protec... strong provisions for adequate affordability. ,...an "enormous disappointment" that creates new and ...
(Date:11/20/2009)...ors and Congressmen in Competitive Re-election Bat...te , Washington, DC (Vocu...unning for re-election next year in races deemed t...ay come to regret voting for House Speaker Nancy P...aking Zogby International/ O’Leary Report p...
(Date:11/20/2009)...Newswire-USNewswire/ -- The American Dental Associ...inistration (FDA) to establish appropriate classif...ing concern about the safety of whitening products...f professional consultation or examination by a de...f chemically based tooth whitening or bleaching ag...
(Date:11/20/2009)..., November 20 Cardio Vas...CVSLMEDICAL.COM , a leading,developer of advanced ... that,the company,s Board of Directors has decided... and the Far East for its proprietary next-generat...plasty (PCTA) procedures. , Cardio Vascul...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...n be removed through the nose using endoscopy rath...//. With this approach, doctors use tiny scope...or with a device that pulverizes and suctions. At ... In the study, which appears in the September/...
... of the American College of Allergy, Asthma and Im...t healthcare providers are not well-equipped to de...at is fatal if not treated immediately//. Th...ducate the patients on the same. The current study...
...hat bronchiolo–alveolar carcinoma frequently shows... The acoustic–physical conditions of the thor...onographic diagnosis of pulmonary diseases. ...n of bacterial pneumonia is predominantly well kno...
... apparently has plagiarised the work of an America...article for a medical journal//. Progress in ...ion was written by Raj Persaud and went unnoticed ...ey teaching hospital in London, and has eight degr...
...ological or neuromuscular diseases are at increase...'re hospitalized with influenza.// The re...f the American Medical Association, are based on a...inding supports recent recommendations that such c...
...ealth sciences have found that more than 70% of sm...top themselves from smoking//. The medical center ...e survey conducted in 1,666 smokers (872 men and 7...% of them were only given correct guidance to quit...
Other Medicine News:Health News:Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus 2Health News:Emergency Treatment Found Wanting In Anaphylactic Reactions 2Health News:Indian Psychiatrist in UK Accused of plagiarism 2Health News:Indian Psychiatrist in UK Accused of plagiarism 3
(Date:11/19/2009)... , TAINAN, Taiwan, Nov. 19 /PRNewswire-Asi...ive pharmaceutical ingredients (APIs), announced t...mpound Safety Certification from,SafeBridge(R) Con...rm,s,competency and proficiency in the safe handli...Is), and applies to specific laboratories and,prod...
(Date:11/19/2009)..., DAYTON, Ohio, Nov. 19 Riverain...partnering with leading Canadian medical imaging d...ed Chest Imaging and OnGuard Chest Xray CAD. The e...iverain Medical,s products to the Canadian market ... sales channel. ,, SoftView Enhanced Chest Imag...
(Date:11/19/2009)... , CAMBRIDGE, Mass., Nov. 19 L... molecule microarray technology to find drugs agai...s raised $1M in seed financing led by incTANK Vent... its initial discovery campaign that will screen o...his investment, incTANK Ventures General Partner C...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 1Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 2Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 3Boot Camp for New Dads Now Working with Renowned Katherine Stone Educating Fathers about Postpartum Depression 53314 4New Study Measures Benefits of More Involved Fathers 53312 1New Study Measures Benefits of More Involved Fathers 53312 2New Study Measures Benefits of More Involved Fathers 53312 3SnoringIsntSexy com Tops 21 000 Site Visits for Second Month in a Row 53311 1SnoringIsntSexy com Tops 21 000 Site Visits for Second Month in a Row 53311 2
...OCKVILLE, Md., May 6 Vanda Pharmaceuticals Inc. (...and Drug Administration (FDA) has granted marketin...te treatment of adult patients with schizophrenia....led Phase III clinical studies comparing Fanapt(TM...chizophrenia, as well as safety data from more tha...
... Presentation describes Palomid 529 as a first-in-...3K/Akt/mTOR pathway showing efficacy in retinal sc... PLAIN, Mass., May 6 Paloma Pharmaceuticals, Inc....TOR Pathway Reduces Photoreceptor Cell Death Follo...e annual meeting of the Association for Research i...
Other Medicine Technology:FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 2FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 3FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 4FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 5FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 6FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia 7Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 2Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 3Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting 4
Padgett Osteotome
Osteotome
Mayo-Hegar Needle Holder
... new Spectral system is a combination Spectral Opt... Ophthalmoscope (SLO) system that provides suberb,... and choroidal-retina structure. With the advancem... scanning rates of up to 27,000 A-Scans per second...
Medicine Products: